The efficacy of oral ribavirin in treatment of Crimean-Congo hemorrhagic fever in Iran

Author(s):
M MardaniM Mardani, M Keshtkar JahromiM Keshtkar Jahromi,*, K Holakoi NainiK Holakoi Naini, M ZinaliM Zinali
*Corresponding Author: Email: [email protected]

Journal of Inflammatory Diseases:Vol. 7, issue 3; 34-38
Published online:Nov 01, 2003
Article type:Research Article
How to Cite:Mardani M, Keshtkar Jahromi M, Holakoi Naini K, Zinali M. The efficacy of oral ribavirin in treatment of Crimean-Congo hemorrhagic fever in Iran. J Inflamm Dis. 2024;7(3):e154958. doi:

Abstract

Background: Crimean-Congo Hemorrhagic fever is a fatal viral disease that occurs in some parts of Africa, Asia, Eastern Europe and Middle-East. Primarily it is a zoonosis but can be seen sporadically in humans. Recently outbreaks have been reported from Pakistan, Afghanistan, Saudi Arabia, United Arab Emirates and Iran. Objective: This study was performed to determine the effecacy of oral ribavirin in treament of CCHF cases by comparing the outcome in two treated and non-treated confirmed CCHF cases. Methods: In this retrospective study 81 confirmed CCHF cases (by serology or viral culture) were evaluated for the incidence of outcome (death or recovery) in the from of an analytic case-control study. Results were analyzed by statistical tests. Findings: From 69 proved CCHF cases who were treated by oral ribavirin and 12 cases who had received no drugs, 61 and 5 cases were survived respectively. Conclusion: Oral ribavirin with an efficacy of 91% can be an effective medical therapy for management of Crimean-Congo hemorrhagic fever.

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

31
Jan
2012

Crimean-Congo Hemorrhagic Fever

Masoud Mardani

Mardani M. Crimean-Congo Hemorrhagic Fever. Arch Clin Infect Dis. 2012;7(1):. doi:

28
Apr
2021
Int J Infect

A Systematic Review of Treatment Strategies Including Future Novel Therapies in Crimean-Congo Hemorrhagic Fever

Hamidreza Kouhpayeh

Kouhpayeh H. A Systematic Review of Treatment Strategies Including Future Novel Therapies in Crimean-Congo Hemorrhagic Fever. Int J Infect. 2021;8(2):e113427. doi: https://doi.org/10.5812/iji.113427

12
Jun
2017

Effects of Dexamethasone on Clinical Outcome in Patients with Severe Crimean-Congo Hemorrhagic Fever

Mohammad Hashemi-Shahri,
Batool Sharifi-Mood,
Alireza Ansari Moghaddam,
Shahabodin Mashaei

Hashemi-Shahri M, Sharifi-Mood B, Ansari Moghaddam A, Mashaei S. Effects of Dexamethasone on Clinical Outcome in Patients with Severe Crimean-Congo Hemorrhagic Fever. Int J Infect. 2017;4(3):e14587. doi: https://doi.org/10.5812/iji.14587

31
Dec
2016

Report of the first case of Crimean Congo hemorrhagic fever in Qazvin province (2016)

A Nikoonejad,
Behzad Bijani

Nikoonejad A, Bijani B. Report of the first case of Crimean Congo hemorrhagic fever in Qazvin province (2016). J Inflamm Dis. 2024;20(5):e155994. doi:

30
Nov
2011

Optional Modalities for Treatment of Patients with Severe Crimean-Congo Hemorrhagic Fever

Batool Sharifi Mood,
Maliheh Metanat,
Roya Alavi Naini,
Masoud Mardani,
Ali Amjadi

Sharifi Mood B, Metanat M, Alavi Naini R, Mardani M, Amjadi A. Optional Modalities for Treatment of Patients with Severe Crimean-Congo Hemorrhagic Fever. Arch Clin Infect Dis. 2011;6(Suppl):. doi:

Download PDF226.17 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles